Just call us when you pull into our special parking stall for this service
A total of 577 patients were randomly assigned (1:1:1) to receive once-weekly dulaglutide (1.5 mg), once-weekly dulaglutide (0.75 mg), or daily insulin glargine as basal therapy, all in combination with insulin lispro, for 52 weeks
The Food and Drug Administration (FDA) currently advises women to stop taking GLP-1 medications like Ozempic at least two months prior to trying to conceive
Skin types: Normal, oily, combination, and dry skin, with particular suitability for those with oily or combination skin seeking brightening without heaviness
Zepbound is the brand name of tirzepatide approved for weight loss, while Mounjaro is FDA-approved for treatment of type 2 diabetes